Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

ARCA Biopharma Inc

Current price
3.4 USD +0.14 USD (+4.29%)
Last closed 3.25 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 46 983 548 USD
Yield for 12 month +71.89 %
21.11.2021 - 28.11.2021

ARCA biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with heart failure. It is developing Recombinant Nematode Anticoagulant Protein c2, a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. The company has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado. Address: 10170 Church Ranch Way, Westminster, CO, United States, 80021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price


P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-111 000 USD

Last Year

-114 000 USD

Current Quarter

-23 000 USD

Last Quarter

-30 000 USD

Key Figures ABIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -7 122 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -11.02 %
PEG Ratio
Return On Equity TTM -13.57 %
Wall Street Target Price 7 USD
Revenue TTM
Book Value 2.55 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -0.37 USD
Diluted Eps TTM -0.37 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ABIO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ABIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:18
Payout Ratio
Last Split Date 04.04.2019
Dividend Date 04.04.2019

Stock Valuation ABIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -1.3579
Price Book MRQ 1.2691

Financials ABIO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ABIO

For 52 weeks

1.56 USD 3.88 USD
50 Day MA 1.91 USD
Shares Short Prior Month 183 582
200 Day MA 1.91 USD
Short Ratio 7.31
Shares Short 195 728
Short Percent 1.89 %

Dynamics of changes in the value of assets




399.12 USD Microsoft Corporation -4.91 (-1.22%)
Detailed analytics

ETF funds



207.85 CHF iShares MDAX UCITS ETF (DE) 0 (0%)
Detailed analytics



2175.88 USD Gold +5.94 (+0.27%)
Detailed analytics